These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36210134)

  • 21. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
    Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
    Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
    Riccardi M; Sammartino AM; Adamo M; Inciardi RM; Lombardi CM; Pugliese NR; Tomasoni D; Vizzardi E; Metra M; Coats AJS; Pagnesi M
    Heart Fail Rev; 2023 Sep; 28(5):1141-1149. PubMed ID: 37198505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
    Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
    Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical and interventional support for heart failure with preserved ejection fraction: A review.
    Gordon JS; Blazoski CM; Wood CT; Zuber C; Massey HT; Throckmorton A; Tchantchaleishvili V
    Artif Organs; 2022 Nov; 46(11):2109-2117. PubMed ID: 35579447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Device-based treatment options for heart failure with preserved ejection fraction.
    Miyagi C; Miyamoto T; Karimov JH; Starling RC; Fukamachi K
    Heart Fail Rev; 2021 Jul; 26(4):749-762. PubMed ID: 33432418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study.
    Granegger M; Gross C; Siemer D; Escher A; Sandner S; Schweiger M; Laufer G; Zimpfer D
    Sci Rep; 2022 Apr; 12(1):5761. PubMed ID: 35388023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure.
    Andrade DC; Arce-Alvarez A; Toledo C; Díaz HS; Lucero C; Schultz HD; Marcus NJ; Del Rio R
    J Appl Physiol (1985); 2017 Sep; 123(3):567-577. PubMed ID: 28620053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Hemodynamic Evaluation at Rest in Heart Failure with Preserved Ejection Fraction.
    Sengeløv M; Biering-Sørensen T
    Heart Fail Clin; 2021 Jul; 17(3):423-434. PubMed ID: 34051974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart failure with preserved ejection fraction (HFpEF)].
    Maeder MT; Buser M; Brenner R; Rickli H
    Ther Umsch; 2018 Sep; 75(3):161-169. PubMed ID: 30145974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Nanayakkara S
    Front Cardiovasc Med; 2019; 6():143. PubMed ID: 31620452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart Failure With Preserved Ejection Fraction.
    Rogers FJ; Gundala T; Ramos JE; Serajian A
    J Am Osteopath Assoc; 2015 Jul; 115(7):432-42. PubMed ID: 26111131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
    Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
    Tromp J; Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Køber L; Swedberg K; Zile MR; Pitt B; Lam CSP; McMurray JJV
    J Am Coll Cardiol; 2019 Aug; 74(5):601-612. PubMed ID: 31370950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing therapies for heart failure with preserved ejection fraction: current state and future directions.
    Butler J; Fonarow GC; Zile MR; Lam CS; Roessig L; Schelbert EB; Shah SJ; Ahmed A; Bonow RO; Cleland JG; Cody RJ; Chioncel O; Collins SP; Dunnmon P; Filippatos G; Lefkowitz MP; Marti CN; McMurray JJ; Misselwitz F; Nodari S; O'Connor C; Pfeffer MA; Pieske B; Pitt B; Rosano G; Sabbah HN; Senni M; Solomon SD; Stockbridge N; Teerlink JR; Georgiopoulou VV; Gheorghiade M
    JACC Heart Fail; 2014 Apr; 2(2):97-112. PubMed ID: 24720916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
    Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac contractility modulation: A new horizon in the management of heart failure with preserved ejection fraction (HFpEF).
    Aneeq A; Jan M; Nisar S; Zahid S; Kumari U
    Cardiovasc Revasc Med; 2024 Apr; 61():110. PubMed ID: 37980262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy.
    Benko J; Samoš M; Bolek T; Prídavková D; Jurica J; Péč MJ; Galajda P; Mokáň M
    J Diabetes Res; 2022; 2022():3366109. PubMed ID: 35296100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
    Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
    Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise Intolerance In Heart Failure With Preserved Ejection Fraction.
    Gupte AA; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2016; 12(2):105-9. PubMed ID: 27486493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.